Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-027984

Chief Development Officer sold 176 shares at $13.11 ($2,307)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Development Officer 2023-06-12 Sale −176 $13.11 $2,307 90,271 D: show line 1 in the form
Open-market sales · 176 sh · avg $13.11 · $2,307
Loading xslF345X04/ownership.xml…